동물용 인공수정 시장 규모, 점유율, 동향 분석 보고서 : 솔루션별, 동물 유형별, 유통 채널별, 지역별 및 부문 예측(2025-2030년)
Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Solutions (Equipment & Consumables, Semen, Services), By Animal Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
상품코드:1726207
리서치사:Grand View Research
발행일:2025년 04월
페이지 정보:영문 160 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
동물용 인공수정 시장 성장과 동향
Grand View Research, Inc.의 최신 보고서에 따르면 세계의 동물용 인공수정 시장 규모는 2030년까지 113억 3,000만 달러에 이를 것으로 추정되며, 2025-2030년의 CAGR은 6.8%를 나타낼 것으로 전망됩니다.
시장 성장을 가속하는 주요 요인으로는 동물성 단백질의 소비량 증가, 가축 생산성에 대한 수요 증가, 유성 정액 채용 등이 있습니다. 2023년 3월, 호주 최대 인공 수정 공급업체인 호주 제네틱스는 동물 인공 수정 업계의 선두주자인 URUS와 합병한다고 발표했습니다.
COVID-19의 유행은 성장 둔화, 판매 마케팅 활동 감소, 공급망 장애, 인공수정 서비스 제공 지연 등 많은 과제를 초래했습니다. 토네크에 의해 악화된 일부 주요 시장에서 불규칙하고 불확실한 소비 패턴은 시장의 불확실성을 더욱 높였습니다. 예를 들어, 지너스는 노동력 부족, 소매 푸드서비스 수요 및 식육 가공 능력에 대한 악영향, 유통에 의한 국제 물류 지연 등을 보고했습니다. COVID-19의 영향이 세계의 양돈 산업, 특히 중국과 유럽에 압력을 가할 것이라고 지적했습니다.
지속적으로 증가하는 고기와 유제품 수요를 충족시키기 위해 시장 관계자는 고품질의 가축을 번식시키고 생산을 강화하는 인공수정 솔루션을 확대하고 있습니다. 2021년 9월, 뉴질랜드에 본사를 둔 농업 기술 협동조합인 LIC는 증가하는 수요를 충족하기 위해 뉴질랜드에 성전환 정액 연구소를 설립했습니다. 이를 통해 협동조합은 2021년 9월부터 12월까지 봄 교배 시즌 동안 약 450만 마리의 소를 인공 수정할 수 있는 능력을 갖추게 되었습니다.
동물용 인공수정 시장 보고서 하이라이트
서비스부문이 2024년에 41.91%의 점유율로 시장을 독점했습니다.
민간 부문은 2024년에 시장에서 가장 큰 수익 점유율을 차지했고 예측 기간 중에 가장 급성장할 것으로 예측되고 있습니다.
The global veterinary artificial insemination market size is estimated to reach USD 11.33 billion by 2030, registering to grow at a CAGR of 6.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In March 2023, Genetics Australia - the country's largest artificial breeding supplier announced that it would merge with URUS - a leading player in the veterinary artificial insemination industry. This would provide Genetics Australia access to global markets in marketing Australian genetics.
The COVID-19 pandemic resulted in many challenges including dampened growth, decreased sales and marketing activities, supply chain hurdles, and delays in the delivery of AI services. The erratic and uncertain consumption patterns in several key markets exacerbated by sporadic lockdowns and logistical bottlenecks further increased the uncertainty in the market. The growth was also dampened by other factors such as the African Swine-Fever. Genus, for instance, reported labor shortages, adverse impact on retail food service demand and meat packing capacity, and international logistics delays due to the pandemic. The company indicated that in the near-term, feed input costs, ASF, and COVID-19 implications would continue to exert pressure on the global porcine industry, particularly in China and Europe. In North America, the pandemic led to packing plant slowdowns during H1 of 2021.
To fulfill the continuously increasing demand for meat and dairy products, market players are expanding artificial insemination solutions to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for U.K. sheep producers. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the cooperative's capabilities to artificially inseminate about 4.5 million cattle between the Spring mating season of September to December 2021. Developing regions such as Latin America are also contributing to the market growth for veterinary artificial insemination. For instance, Brazil, one of the major countries in the region has been adopting AI increasingly for the past decade. The country has also deployed Fixed-Time Artificial Insemination (FTAI) techniques to increase profitability and success rate.
The services segment dominated the market with a share of 41.91% in 2024. These include AI service execution, reproduction management, semen evaluation & analysis, genetic consultations, and training & education.
The private segment accounted for the largest revenue share of the market in 2024 and is projected to grow the fastest over the forecast period.
In 2024, the bovine segment accounted for the largest share of the market by animal type. This dominance can be mainly attributed to two factors, the population and the contribution to the milk production.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR's Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Artificial Insemination Industry Outlook
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for meat, dairy, and dairy products
3.2.1.2. Increasing need for sustainable food production
3.2.1.3. Advancements in animal reproduction technology
3.2.1.4. Supportive Initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of awareness
3.2.2.2. Limited access to supplies & skilled labor in certain countries
